These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7828674)
1. Influence of alloreactive T cells on initial hematopoietic reconstitution after marrow transplantation. Martin PJ Exp Hematol; 1995 Feb; 23(2):174-9. PubMed ID: 7828674 [TBL] [Abstract][Full Text] [Related]
2. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice. Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296 [TBL] [Abstract][Full Text] [Related]
3. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. Drobyski WR; Majewski D; Hanson G Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102 [TBL] [Abstract][Full Text] [Related]
4. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. Drobyski WR; Majewski D; Ozker K; Hanson G J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263 [TBL] [Abstract][Full Text] [Related]
5. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution. Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113 [TBL] [Abstract][Full Text] [Related]
6. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors. Schwartz E; Lapidot T; Gozes D; Singer TS; Reisner Y J Immunol; 1987 Jan; 138(2):460-5. PubMed ID: 3098843 [TBL] [Abstract][Full Text] [Related]
7. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Shizuru JA; Jerabek L; Edwards CT; Weissman IL Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349 [TBL] [Abstract][Full Text] [Related]
8. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma. Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005 [TBL] [Abstract][Full Text] [Related]
10. Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction. Iwasaki T; Fujiwara H; Iwasaki T; Shearer GM J Immunol; 1986 Nov; 137(10):3100-8. PubMed ID: 2945856 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppression by succinylacetone. II. Prevention of graft-vs-host disease. Hess RA; Tschudy DP; Blaese RM J Immunol; 1987 Nov; 139(9):2845-9. PubMed ID: 2889780 [TBL] [Abstract][Full Text] [Related]
12. [Effect of natural killer cell on hematopoiesis and immunity recovery in mouse allogeneic bone marrow transplantation]. Yang ZG; Zeng YY; He XH; Wang Q; Jiang X Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):713-6. PubMed ID: 15730711 [TBL] [Abstract][Full Text] [Related]
13. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation. Strober S Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036 [TBL] [Abstract][Full Text] [Related]
15. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Li JM; Waller EK Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532 [TBL] [Abstract][Full Text] [Related]
16. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells. Murphy WJ; Kumar V; Cope JC; Bennett M J Immunol; 1990 May; 144(9):3305-11. PubMed ID: 2329274 [TBL] [Abstract][Full Text] [Related]
17. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746 [TBL] [Abstract][Full Text] [Related]
18. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation]. He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957 [TBL] [Abstract][Full Text] [Related]
19. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice. Pruijt JF; Lindley IJ; Heemskerk DP; Willemze R; Fibbe WE Stem Cells; 1997; 15(1):50-5. PubMed ID: 9007222 [TBL] [Abstract][Full Text] [Related]
20. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model. Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]